Industry › Clinical Trials
Press Releases
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed
Essex Bio-Technology Limited
Jul 26, 2023 18:58 HKT/SGT
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
HanchorBio Inc
Jul 24, 2023 20:19 HKT/SGT
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
HanchorBio Inc
Jul 24, 2023 19:30 HKT/SGT
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK
ADICON Holdings Limited
Jun 30, 2023 14:25 HKT/SGT
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share
ADICON Holdings Limited
Jun 19, 2023 11:37 HKT/SGT
アバンセ・クリニカルがASCO & BIO 2023に参加 初期段階のオンコロジー試験はより精緻化、より多くの患者を必要とする
Avance Clinical
May 30, 2023 20:00 JST
ASCO & BIO 2023에서 아방스 임상: 점점 더 정교해지고 더 많은 환자를 요구하는 초기 단계 종양학 시험
Avance Clinical
May 30, 2023 11:00 HKT/SGT
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
Avance Clinical
May 30, 2023 10:00 HKT/SGT